Clinical and epidemiological research
We have a strong focus on unraveling the clinical relevance and the outcome of infections in patients with cancer. Here, we focus on respiratory viruses and conduct registry-studies within the cooperation OncoReVir.
An example for this work is a first analysis of the epidemiology of influenza-virus infections in cancer patients (n=210) that revealed super-infections as the most relevant risk factor for mortality (Hermann et al., Eur J Clin Microbiol Infect Dis 2017).
In addition, we investigate the role of azole-resistant Aspergillus spp. in all patient populations together with the NRZMyk and we collaborate with the University Hospital Düsseldorf in the German Keratomycosis-Registry.